|
US79726A
(en)
*
|
|
1868-07-07 |
|
Hbney bfllard |
|
JPS5245474B2
(enExample)
|
1972-04-19 |
1977-11-16 |
|
|
|
JPS5417754B2
(enExample)
|
1972-12-15 |
1979-07-02 |
|
|
|
CA1022544A
(en)
|
1972-12-21 |
1977-12-13 |
Yukiyasu Murakami |
Process of preparing a heterocyclic acyl group-substituted cephalosporin derivative
|
|
JPS587637B2
(ja)
|
1973-12-27 |
1983-02-10 |
住友化学工業株式会社 |
シンキペニシリンノ セイホウ
|
|
AT328085B
(de)
|
1974-04-23 |
1976-03-10 |
Sumitomo Chemical Co |
Verfahren zur herstellung neuer penicilline
|
|
US4215123A
(en)
|
1979-05-07 |
1980-07-29 |
American Home Products Corporation |
Antisecretory 4-oxy-3-carboxy or cyano-1,2-dihydro-2-oxo-1,8-naphthyridine derivatives
|
|
US4468394A
(en)
|
1981-04-02 |
1984-08-28 |
Eisai Co., Ltd. |
Cephalosporin compounds
|
|
US4374138A
(en)
|
1981-11-13 |
1983-02-15 |
Warner-Lambert Company |
Antibacterial amide compounds, compositions, and methods of use
|
|
US4404201A
(en)
|
1981-11-13 |
1983-09-13 |
Warner-Lambert Company |
Cephalosporins
|
|
US4382089A
(en)
|
1982-03-02 |
1983-05-03 |
Warner-Lambert Company |
Antibacterial amide compounds, compositions thereof and methods of using them
|
|
US4710473A
(en)
|
1983-08-10 |
1987-12-01 |
Amgen, Inc. |
DNA plasmids
|
|
US5037826A
(en)
|
1986-10-15 |
1991-08-06 |
Schering Corporation |
1-substituted naphthyridine and pyridopyrazine derivatives
|
|
SU1735288A1
(ru)
|
1990-03-05 |
1992-05-23 |
Харьковский государственный фармацевтический институт |
Способ получени N-R-замещенных амидов 4-гидроксихинолон-2 карбоновой -3-кислоты
|
|
JP2988739B2
(ja)
|
1990-04-16 |
1999-12-13 |
協和醗酵工業株式会社 |
１，８−ナフチリジン−２−オン誘導体
|
|
JPH0493592A
(ja)
|
1990-08-09 |
1992-03-26 |
Nissan Motor Co Ltd |
回転蓄熱式熱交換器
|
|
IL100917A0
(en)
|
1991-02-16 |
1992-11-15 |
Fisons Plc |
Pyridinone and pyrimidinone derivatives,their preparation and pharmaceutical compositions containing them
|
|
US5155115A
(en)
|
1991-03-12 |
1992-10-13 |
Kyowa Hakko Kogyo Co., Ltd. |
Thienopyridine derivatives
|
|
DE4138820A1
(de)
|
1991-11-26 |
1993-05-27 |
Basf Ag |
Chinolin-3-carbonsaeureamide, deren herstellung und verwendung
|
|
AU668694B2
(en)
|
1991-12-19 |
1996-05-16 |
Sanofi-Synthelabo |
Saccharin derivative proteolytic enzyme inhibitors
|
|
DE4227747A1
(de)
|
1992-08-21 |
1994-02-24 |
Basf Ag |
Heteroaromatisch kondensierte Hydroxypyridoncarbonsäureamide, deren Herstellung und Verwendung
|
|
US5502035A
(en)
|
1993-08-06 |
1996-03-26 |
Tap Holdings Inc. |
N-terminus modified analogs of LHRH
|
|
TW406076B
(en)
|
1993-12-30 |
2000-09-21 |
Hoechst Ag |
Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals
|
|
JPH07224040A
(ja)
|
1994-02-07 |
1995-08-22 |
Fujisawa Pharmaceut Co Ltd |
キノリン誘導体
|
|
IL135495A
(en)
|
1995-09-28 |
2002-12-01 |
Hoechst Ag |
Intermediate compounds for the preparation of quinoline-converted amines - 2 - carboxylic acid
|
|
DE19746287A1
(de)
|
1997-10-20 |
1999-04-22 |
Hoechst Marion Roussel De Gmbh |
Substituierte Isochinolin-2-Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
|
|
CA2260499A1
(en)
|
1998-01-29 |
1999-07-29 |
Sumitomo Pharmaceuticals Company Limited |
Pharmaceutical compositions for the treatment of ischemic brain damage
|
|
US6133285A
(en)
|
1998-07-15 |
2000-10-17 |
Active Biotech Ab |
Quinoline derivatives
|
|
GB9911047D0
(en)
|
1999-05-12 |
1999-07-14 |
Isis Innovation |
Assay method and means
|
|
AU2001252671A1
(en)
|
2000-05-12 |
2001-11-20 |
Kyorin Pharmaceutical Co. Ltd. |
Pyridobenzodiazine derivatives and processes for the preparation thereof
|
|
JP4272338B2
(ja)
|
2000-09-22 |
2009-06-03 |
バイエル アクチェンゲゼルシャフト |
ピリジン誘導体
|
|
AU2002303145A1
(en)
|
2001-03-23 |
2002-10-08 |
Smithkline Beecham Corporation |
Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases
|
|
CN102526045A
(zh)
|
2001-12-06 |
2012-07-04 |
法布罗根股份有限公司 |
提高内源性红细胞生成素(epo)的方法
|
|
DE60322920D1
(de)
|
2002-08-13 |
2008-09-25 |
Shionogi & Co |
Heterocyclische verbindungen mit hiv-integrase-hemmender wirkung
|
|
WO2004037853A2
(en)
|
2002-10-21 |
2004-05-06 |
Irm Llc |
Quinolones with anti-hiv activity
|
|
US7618940B2
(en)
|
2002-12-06 |
2009-11-17 |
Fibrogen, Inc. |
Fat regulation
|
|
WO2004104000A1
(ja)
|
2003-05-23 |
2004-12-02 |
Japan Tobacco Inc. |
トリサイクリック縮合環化合物およびその医薬用途
|
|
WO2004103974A1
(ja)
|
2003-05-23 |
2004-12-02 |
Japan Tobacco Inc. |
置換２－オキソキノリン化合物およびその医薬用途
|
|
US8614204B2
(en)
|
2003-06-06 |
2013-12-24 |
Fibrogen, Inc. |
Enhanced erythropoiesis and iron metabolism
|
|
WO2005007192A2
(en)
|
2003-06-06 |
2005-01-27 |
Fibrogen, Inc. |
Cytoprotection through the use of hif hydroxylase inhibitors
|
|
KR100932169B1
(ko)
|
2003-06-06 |
2009-12-16 |
피브로겐, 인크. |
질소-함유 헤테로아릴 화합물 및 내인성 적혈구생성소의증가에서의 그들의 사용
|
|
JP4057972B2
(ja)
*
|
2003-07-25 |
2008-03-05 |
富士通株式会社 |
半導体装置の製造方法
|
|
EP1658074B1
(en)
|
2003-08-01 |
2012-11-07 |
Fibrogen, Inc. |
Inhibitors of 2-oxoglutarate dioxygenase as gamma globin inducers
|
|
AU2004268941A1
(en)
|
2003-08-22 |
2005-03-10 |
Avanir Pharmaceuticals |
Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases
|
|
US7378414B2
(en)
|
2003-08-25 |
2008-05-27 |
Abbott Laboratories |
Anti-infective agents
|
|
JP2007510649A
(ja)
|
2003-11-04 |
2007-04-26 |
メルク エンド カムパニー インコーポレーテッド |
置換ナフチリジノン誘導体
|
|
EP1720856B1
(en)
|
2004-02-11 |
2013-08-14 |
GlaxoSmithKline LLC |
Hiv integrase inhibitors
|
|
BRPI0511267A
(pt)
|
2004-05-17 |
2007-11-27 |
Tibotec Pharm Ltd |
1,5-diidropirido[3,2-b]indol-2-onas 4-substituìdas
|
|
JPWO2006088246A1
(ja)
|
2005-02-18 |
2008-07-10 |
武田薬品工業株式会社 |
Ｇｐｒ３４受容体機能調節剤
|
|
CN101166745A
(zh)
|
2005-03-02 |
2008-04-23 |
菲布罗根有限公司 |
噻吩并吡啶化合物和其使用方法
|
|
AR055319A1
(es)
|
2005-03-17 |
2007-08-15 |
Wyeth Corp |
Derivados de isoquinoleina, composiciones farmaceuticas y usos
|
|
US20060276477A1
(en)
|
2005-06-06 |
2006-12-07 |
Fibrogen, Inc. |
Treatment method for anemia
|
|
ATE470439T1
(de)
|
2005-06-15 |
2010-06-15 |
Fibrogen Inc |
Verwendung von hif 1alfa modulatoren zur behandlung von krebs
|
|
WO2007038571A2
(en)
*
|
2005-09-26 |
2007-04-05 |
Smithkline Beecham Corporation |
Prolyl hydroxylase antagonists
|
|
AU2006326662B2
(en)
|
2005-12-09 |
2011-07-28 |
Amgen Inc. |
Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof
|
|
KR20080097446A
(ko)
|
2006-02-16 |
2008-11-05 |
피브로겐, 인크. |
뇌졸중의 치료를 위한 화합물과 방법
|
|
US7625927B2
(en)
|
2006-02-27 |
2009-12-01 |
Alcon Research, Ltd. |
Method of treating glaucoma
|
|
AR059733A1
(es)
|
2006-03-07 |
2008-04-23 |
Smithkline Beecham Corp |
Compuesto derivado de glicina n- sustituida con heteroaromaticos bicicicos, composicion farmaceutica que lo comprende, uso para preparar un medicamento para tratar la anemia y proceso para su preparacion
|
|
WO2007136990A2
(en)
|
2006-05-16 |
2007-11-29 |
Smithkline Beecham Corporation |
Prolyl hydroxylase inhibitors
|
|
JO2934B1
(en)
|
2006-06-23 |
2015-09-15 |
سميث كلاين بيتشام كوربوريشن |
Prolyl hydroxylase inhibitors
|
|
JP4876041B2
(ja)
|
2006-08-30 |
2012-02-15 |
株式会社リコー |
画像形成装置
|
|
WO2008040002A2
(en)
|
2006-09-28 |
2008-04-03 |
Fred Hutchinson Cancer Research Center |
Methods, compositions and articles of manufacture for hif modulating compounds
|
|
EP2111399A2
(en)
*
|
2006-12-18 |
2009-10-28 |
Amgen Inc. |
Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
|
|
ES2393326T3
(es)
*
|
2006-12-18 |
2012-12-20 |
Amgen, Inc |
Compuestos basados en azaquinolona que presentan actividad inhibidora de prolil hidroxilasas, composiciones y usos de los mismos
|
|
TW200845994A
(en)
|
2007-01-12 |
2008-12-01 |
Smithkline Beecham Corp |
N-substituted glycine derivatives: prolyl hydroxylase inhibitors
|
|
EP2142509B1
(en)
*
|
2007-04-18 |
2013-12-04 |
Amgen, Inc |
Quinolones and azaquinolones that inhibit prolyl hydroxylase
|
|
WO2008137084A2
(en)
*
|
2007-05-04 |
2008-11-13 |
Amgen Inc. |
Diazaquinolones that inhibit prolyl hydroxylase activity
|
|
US8030346B2
(en)
*
|
2007-05-04 |
2011-10-04 |
Amgen Inc. |
Heterocyclic quinolone derivatives that inhibit prolyl hydroxylase activity
|